Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells. | Nat Immunol | 2024 | 38278966 | PubTator, text mining | PubMed |
| Porcine epidemic diarrhea virus strain CH/HLJ/18 isolated in China: characterization and phylogenetic analysis. | Virol J | 2024 | 38268010 | PubTator, text mining | PubMed |
| Favipiravir Analogues as Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase, Combined Quantum Chemical Modeling, Quantitative Structure-Property Relationship, and Molecular Docking Study. | Molecules | 2024 | 38257352 | PubTator, text mining | PubMed |
| After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives. | Int J Mol Sci | 2024 | 38255813 | PubTator, text mining | PubMed |
| Amplification-free detection of Mpox virus DNA using Cas12a and multiple crRNAs. | Mikrochim Acta | 2024 | 38231433 | PubTator, text mining | PubMed |
| Two-Stage Recognition Mechanism of the SARS-CoV-2 Receptor-Binding Domain to Angiotensin-Converting Enzyme-2 (ACE2). | Int J Mol Sci | 2024 | 38203850 | PubTator, text mining | PubMed |
| Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies. | mBio | 2024 | 38193697 | PubTator, text mining | PubMed |
| Genetic regions affecting the replication and pathogenicity of dengue virus type 2. | PLoS Negl Trop Dis | 2024 | 38190404 | PubTator, text mining | PubMed |
| Rapid assays of SARS-CoV-2 virus and noble biosensors by nanomaterials. | Nano Converg | 2024 | 38190075 | PubTator, text mining | PubMed |
| Intra-serotypic antigenic diversity of dengue virus serotype 3 in Thailand during 2004-2015. | Epidemiol Infect | 2024 | 38185822 | PubTator, text mining | PubMed |
| Omicron and Delta variant prevalence detection and identification during the fourth COVID-19 wave in Mexico using wastewater-based epidemiology. | IJID Reg | 2024 | 38149263 | PubTator, text mining | PubMed |
| Unveiling tetrahydroquinolines as promising BVDV entry inhibitors: Targeting the envelope protein. | Virology | 2024 | 38141499 | PubTator, text mining | PubMed |
| A short sequence in the tail of SARS-CoV-2 envelope protein controls accessibility of its PDZ-binding motif to the cytoplasm. | J Biol Chem | 2024 | 38110034 | PubTator, text mining | PubMed |
| Comparative analysis of SARS-CoV-2 variants Alpha (B.1.1.7), Gamma (P.1), Zeta (P.2) and Delta (B.1.617.2) in Vero-E6 cells: ultrastructural characterization of cytopathology and replication kinetics. | Braz J Infect Dis | 2024 | 38081327 | PubTator, text mining | PubMed |
| Environmental monitoring of SARS-CoV-2 in the metropolitan area of Porto Alegre, Rio Grande do Sul (RS), Brazil. | Environ Sci Pollut Res Int | 2024 | 38057673 | PubTator, text mining | PubMed |
| ASFV epitope mapping by high density peptides microarrays. | Virus Res | 2024 | 38029799 | PubTator, text mining | PubMed |
| White spot syndrome virus hijacks host PP2A-FOXO axes to promote its propagation. | Int J Biol Macromol | 2024 | 38007022 | PubTator, text mining | PubMed |
| How the immune response to the structural proteins of SARS-CoV-2 affects the retinal vascular endothelial cells: an immune thrombotic and/or endotheliopathy process with in silico modeling. | Immunol Res | 2024 | 37642808 | PubTator, text mining | PubMed |
| Development of a Single-Chain Fragment Variable that Binds to the SARS-CoV-2 Spike Protein Produced by Genetically Modified Lactic Acid Bacteria. | Mol Biotechnol | 2024 | 37060514 | PubTator, text mining | PubMed |
| The recombinant truncated envelope protein of West Nile virus adjuvanted with Alum/CpG induces potent humoral and T cell immunity in mice. | Biosaf Health | 2023 | 40078908 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=10